In their study, reversal of hyperglucagonemia by liraglutide or a glucagon-neutralizing antibody does not suppress increased hepatic gluconeogenic expression or improve blood glucose control but does attenuate ketosis in uncontrolled diabetes [41]. This evidence concerns the gene GCG and diabetes mellitus.